These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7999264)

  • 21. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
    Wittekindt NE; Würgler FE; Sengstag C
    DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
    Daniels JM; Massey TE
    Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity.
    Eugster HP; Bärtsch S; Würgler FE; Sengstag C
    Biochem Biophys Res Commun; 1992 Jun; 185(2):641-7. PubMed ID: 1610357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
    Shiota N; Kodama S; Inui H; Ohkawa H
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s.
    Urban P; Truan G; Gautier JC; Pompon D
    Biochem Soc Trans; 1993 Nov; 21(4):1028-34. PubMed ID: 8131892
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line.
    Stettler PM; Sengstag C
    Mol Carcinog; 2001 Jul; 31(3):125-38. PubMed ID: 11479921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers.
    Sunouchi M; Fukuhara M; Ohno Y; Takanaka A
    J Toxicol Sci; 1988 Nov; 13(4):193-204. PubMed ID: 3149679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells.
    Preisler V; Caspary WJ; Hoppe F; Hagen R; Stopper H
    Mutagenesis; 2000 Jan; 15(1):91-7. PubMed ID: 10640536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic effects of promutagens in genetically engineered V79 Chinese hamster cells expressing cytochromes P450.
    Kulka U; Doehmer J; Glatt HR; Bauchinger M
    Eur J Pharmacol; 1993 Apr; 228(5-6):299-304. PubMed ID: 8482321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CYP1A1-activated aneugenicity of aflatoxin B1 in mammalian cells and its combined effect with benzo(a)pyrene.
    Wang H; Fan Q; Liang Q; Wu Y; Ye Z; Wu H; Sun Q; Tang H; Liu Y; Liu Q; Chen Y
    Chem Biol Interact; 2024 Apr; 392():110923. PubMed ID: 38382706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
    Gautier JC; Urban P; Beaune P; Pompon D
    Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.
    Guo Y; Breeden LL; Zarbl H; Preston BD; Eaton DL
    Mol Cell Biol; 2005 Jul; 25(14):5823-33. PubMed ID: 15988000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
    Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
    Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae.
    Fasullo M; Freedland J; St John N; Cera C; Egner P; Hartog M; Ding X
    Environ Mol Mutagen; 2017 May; 58(4):217-227. PubMed ID: 28436563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment.
    Liu L; Nakatsu K; Massey TE
    Arch Toxicol; 1993; 67(6):379-85. PubMed ID: 8215906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.
    Arlt VM; Stiborová M; Henderson CJ; Thiemann M; Frei E; Aimová D; Singh R; Gamboa da Costa G; Schmitz OJ; Farmer PB; Wolf CR; Phillips DH
    Carcinogenesis; 2008 Mar; 29(3):656-65. PubMed ID: 18204078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.